Urgo Medical North America, a prominent player in the wound care industry, is headquartered in the United States. Founded in 2018, the company has quickly established itself as a leader in advanced wound management solutions, focusing on innovative products that enhance healing and improve patient outcomes. With a strong presence across North America, Urgo Medical North America offers a diverse range of core products, including advanced dressings and innovative therapies that utilise unique technologies. Their commitment to research and development has led to notable achievements, positioning them as a trusted partner in healthcare. Recognised for their dedication to quality and efficacy, Urgo Medical North America continues to set benchmarks in the industry, striving to meet the evolving needs of healthcare professionals and patients alike.
How does Urgo Medical North America's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Urgo Medical North America's score of 18 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Urgo Medical North America currently does not report any specific carbon emissions data, as there are no available figures for kg CO2e emissions. The company is a current subsidiary of Urgo Medical North America, and as such, it does not inherit emissions data from a parent company. In terms of climate commitments, Urgo Medical North America has not established any documented reduction targets or initiatives, nor does it participate in recognised climate pledges such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As the organisation continues to develop its sustainability strategy, it is essential for Urgo Medical North America to consider setting measurable targets and participating in industry-standard climate initiatives to enhance its environmental impact and transparency.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Urgo Medical North America has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

